Expression of miR-210 in relation to other measures of hypoxia and prediction of benefit from hypoxia modification in patients with bladder cancer.

Br J Cancer · 2016 · PMC4997544 · PMID 27441495

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

a strong trendP =0.08so close (0.05 < p ≤ 0.1)

More interestingly, patients with low miR-210 without necrosis show a strong trend that CON treatment may not be suitable (5-year OS was 55.3% for RT and 24.3% for RT+CON, log-rank P =0.08, HR 0.51, 95% CI 0.24–1.09; Figure 4B ).

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.